Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Opiate Addiction

In brief

The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects

Key facts

Study ID

NCT00829777

Run by

California Pacific Medical Center Research Institute

People needed

8

Starts

2009-03-01

Expected to finish

2009-09-01

Last updated by the study team

2009-09-16

Who can join

Age: 21 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Opiate dependent males and females age 21-45 on stable doses of methadone
• Fluent English speaker
• Willing and able to give written consent

You may not qualify if…

• Pregnancy or lactation
• FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.

Where it is running

• CPMC Addiction & Pharmacology Research Laboratory (APRL) — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.